Skip to main content

Day: March 23, 2021

Teleste Corporation: Managers’ Transactions – Hyytiäinen

TELESTE CORPORATION   MANAGERS’ TRANSACTIONS 23.3.2021 AT 09:00 EET Teleste Oyj – Managers’ Transactions ____________________________________________ Person subject to the notification requirement Name: Hyytiäinen, Juha Position: Chief Financial Officer Issuer: Teleste Oyj LEI: 743700CJRQRU0007GN59 Notification type: INITIAL NOTIFICATION Reference number: 743700CJRQRU0007GN59_20210318103023_2 ____________________________________________ Transaction date: 2021-03-19 Venue not applicable Instrument type: SHARE ISIN: FI0009007728 Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE OR REMUNERATION (X) Linked to stock option programme Transaction details (1): Volume: 302 Unit price:  N/A Aggregated transactions (1): Volume: 302 Volume weighted average price:  N/A TELESTE CORPORATION Additional information:SVP HR...

Continue reading

NewHydrogen provides green hydrogen technology development update

SANTA CLARITA, Calif., March 23, 2021 (GLOBE NEWSWIRE) — NewHydrogen, Inc., a BioSolar company (OTC:BSRC), today provided an update on the progress of its green hydrogen technology development under a sponsored research agreement with the University of California at Los Angeles (UCLA). The company recently announced that it had executed an agreement, replacing the predecessor, to expand ten-fold upon the research efforts. The initial sponsored research program at UCLA focused on replacing the oxygen catalyst, iridium, a precious metal found only in asteroids, with low cost, earth-abundant materials that meet or exceed the performance characteristics of iridium. The objective is to develop inexpensive and robust materials with an outstanding ability to catalyze the electrochemical oxygen evolution reaction (OER) while achieving overall...

Continue reading

Logiq Partners with Comviva to Offer Digital Wallet and Payment Services to Millions of Mobile Users Across Indonesia

NOT FOR DISTRIBUTION IN CANADA NEW DELHI, India and NEW YORK, March 22, 2021 (GLOBE NEWSWIRE) — Logiq, Inc. (OTCQX: LGIQ), a global provider of award-winning eCommerce and fintech solutions, has joined forces with Comviva, a global leader in digital financial solutions, to offer digital wallet and payment services across Indonesia. The services based on Logiq’s PayLogiq digital wallet will be powered by Comviva’s mobiquity® Pay platform. Logiq also recently partnered with Yabx, a fintech venture of Comviva to offer credit-based financial services such as cash advance for merchants and ‘buy now, pay later’ (BNPL) options for consumers. mobiquity Pay is one of the world’s largest digital wallet solutions, powering over 70 digital financial services across more than 50 countries and will play an essential role in Logiq’s new partnership...

Continue reading

Musk Metals Acquires the “Elon” Lithium Property in Quebec

VANCOUVER, British Columbia, March 23, 2021 (GLOBE NEWSWIRE) — Musk Metals Corp. (“Musk Metals” or the “Company”) (CSE: MUSK) (OTC: GPMNF) (FSE: 1I3) is pleased to announce that it has entered into an agreement to acquire a 100% interest in the prospective “Elon” Lithium property that spans over 245 hectares in the La Corne and Fiedmont townships of Quebec, approximately 40 kilometres north of the mining town of Val d’Or. The Property is strategically located approximately 600 meters northeast of the Lithium Amérique du Nord (“North American”) project (formerly Mine Québec Lithium), which produced over 907,000 tonnes of material, at 1.40% Li2O from 1955 to 1965 (Boily et al, 1989). The Elon lithium property has excellent infrastructure support with road network, railway, electricity, water, and trained manpower available locally....

Continue reading

New phase III data shows investigational antibody cocktail casirivimab and imdevimab reduced hospitalisation or death by 70% in non-hospitalised patients with COVID-19

Investigational antibody cocktail of casirivimab and imdevimab also significantly shortened the duration of symptoms by four days The 2,400 mg and 1,200 mg doses tested in the phase III study had similar efficacy across all endpoints Companion dose-ranging phase II trial showed significant and comparable viral reductions for a range of doses of casirivimab and imdevimab The combination of casirivimab and imdevimab is the only monoclonal antibody treatment to retain potency against key emerging variants, based on the recently updated EUA guidance from the U.S. FDA1             Basel, 23 March 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today confirmed positive topline results from the largest trial to date assessing a COVID-19 treatment in infected non-hospitalised patients (n=4,567; REGN-COV 2067). The phase III outcomes trial...

Continue reading

ABC arbitrage : Résultats annuels 2020

  Communiqué de presse Paris, le 23 mars 20211 – 07h00Résultat 2020 : 35,1 M€ ROE 2020 : 23,9%   Le conseil d’administration d’ABC arbitrage s’est réuni le 18 mars 2021 sous la présidence de Dominique Ceolin pour arrêter les comptes consolidés de l’exercice 2020. Les données financières se caractérisent comme suit :  31/12/2020 IFRS 31/12/2019 IFRSProduit de l’activité courante 68,8 M€ 37,2 M€Résultat net part du groupe 35,1 M€ 18,3 M€Bénéfice net par action (BNPA) 0,60 € 0,31 €Rendement Net (ROE) 23,9% 12,8%ActivitéLa crise sanitaire a engendré en 2020 une vague d’incertitudes rarement rencontrée. Le contexte de marché a été statistiquement exceptionnel. La moyenne de l’indice de référence de la volatilité (VIX) s’élève à 29,3% vs 15,4% sur l’année 2019. Le premier semestre de l’année 2020 se caractérise...

Continue reading

ABC arbitrage: 2020 Results

  Press release Paris, march 23, 20211 – 07h002020 Results: €35.1 M€ 2020 ROE: 23.9%   The Board of Directors of ABC arbitrage, presided by the Chairman Dominique Ceolin, met on March 18, 2021 to approve the consolidated financial statements for fiscal year 2020.The financial data are as follows:  Dec. 31, 2020 IFRS Dec. 31, 2019 IFRSNet revenues €68.8m €37.2mNet income €35.1m €18.3mEarnings per share (EPS) €0.60 €0.31Return On Equity (ROE) 23.9% 12.8%Business Performance In 2020, the health crisis generated a wave of uncertainty rarely encountered. The market environment was statistically exceptional. The average of the benchmark volatility index (VIX) was 29.3% vs. 15.4% for the year 2019. The first half of 2020 was characterized by a more violent shock of volatility in March than what was observed during...

Continue reading

Roche launches new high throughput configurations for cobas pro integrated solutions to increase testing efficiency

With eight new configurations, cobas pro® integrated solutions offers labs greater flexibility to ramp up their testing capacity to adapt to evolving testing needs This will allow a greater number of patient samples to be processed faster By consolidating up to four analytical units on a single platform, testing efficiency in high-volume labs is increasedBasel, 23 March 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the launch of eight new configurations for cobas pro integrated solutions, in countries accepting the CE mark. As a result, this analyser can deliver up to 4,400 tests per hour, doubling its previous testing capacity.1 This makes it the ideal choice for labs seeking greater flexibility in ramping up their testing capacity, to adapt to evolving clinical chemistry and immunochemistry testing needs. Today, the importance...

Continue reading

Private Placement Markets beings its 144A Bond Funding Program for Real Estate Loans

Steve Muehler, the Founder & Senior Managing Member of Private Placement Markets, today announced that the firm has successfully launched new 144A Bond Funding Program for Real Estate Loan associated with the Firms Commercial Real Estate Asset Backed Certificates Market & its Commercial Multifamily Real Estate Asset Backed Certificates Market. According to Steve Muehler, “the 144A Bond Funding Program for Commercial Real Estate Loans is a fast, low-cost, non-recourse way to finance many types of real estate and non-real estate projects. The 144A Bond Program was put into place by the SEC to facilitate the resale of privately placed securities that are unregistered. This program is part of a 1990 SEC rule to make more liquid and efficient institutional resale market for unregistered securities.” NOTE: Private Placement Markets...

Continue reading

Remote Workers in the Crosshairs: Mimecast Publishes New Report Detailing Threat Actor Attacks During “The Year of Social Distancing”

LEXINGTON, Mass., March 23, 2021 (GLOBE NEWSWIRE) — Mimecast Limited (NASDAQ: MIME), a leading email security and cyber resilience company, today announced the publication of its new “The Year of Social Distancing” global report. Drawing on data from the Mimecast threat intelligence team, the report details how threat actors targeted remote workers during the first year of the pandemic, March 2020 – February 2021. The report describes how attack volume surged by 48% during the first year of the pandemic, with sudden increases in volume corresponding to spikes in COVID-19 infection rates in April and October 2020. “Threat actors took advantage of the pandemic to launch a torrent of COVID-19-themed social engineering attacks, understanding that people were under stress working in the home environment, and thus more likely to be deceived...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.